Inspire Medical Systems Inc
NYSE:INSP
Inspire Medical Systems Inc
NYSE:INSP
Price:
154.525 USD
-2.83%
Market Closed
Updated:
May 17, 2024
Inspire Medical Systems Inc
Research & Development
|
Inspire Medical Systems Inc
Research & Development Peer Comparison
Comparables:
VEEV
EVH
DOCS
CERT
GDRX
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$119.8m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$629m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-37%
|
|
|
Evolent Health Inc
NYSE:EVH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$80.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Research & Development
-$34.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Research & Development
-$135.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is Inspire Medical Systems Inc's Research & Development?
Research & Development
-119.8m
USD
-119.8m
USD
Based on the financial report for Mar 31, 2024, Inspire Medical Systems Inc's Research & Development amounts to -119.8m USD.
What is Inspire Medical Systems Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-71%
-71%
Over the last year, the Research & Development growth was -46%. The average annual Research & Development growth rates for Inspire Medical Systems Inc have been -61% over the past three years , -71% over the past five years .
You don't have any saved screeners yet
